Casibrain secures market approval for world's first non-invasive whole-brain multi-channel cerebral oximetry monitor in China

Non-invasive Whole-brain Multi-channel Cerebral Oxygen Monitor Product Appearance

The successful launch of the Non-invasive Whole-brain Multi-channel Cerebral Oxygen Monitor marks a groundbreaking advancement in the field of global non-invasive brain function monitoring—officially transitioning from "single-point monitoring" to a new era of "panoramic monitoring." Simultaneously, this product expands the application scenarios of non-invasive cerebral oximetry: from primarily being used in anesthesia procedures to extending into broader fields such as neurosurgery, intensive care, and stroke prevention and treatment. It particularly addresses the critical needs of stroke centers for precise diagnosis, treatment, and rehabilitation assessment in real clinical settings.

In the fields of neurosurgery, intensive care, and stroke management, continuous and precise monitoring of cerebral tissue oxygen saturation is crucial for assessing brain function status and providing early warning of cerebral ischemia risk.

However, clinical practice in this area has long been constrained by a critical bottleneck: the lack of a method capable of real-time, continuous, and objectively quantitative monitoring of cerebral blood oxygen. While traditional imaging examinations such as DSA, CT, and MRI can provide objective imaging evidence, they are limited by procedural timeliness and cannot achieve continuous monitoring. Conversely, conventional neurological function assessments rely on physicians' subjective judgment, often suffering from insufficient specificity and significant inter-rater variability. More importantly, as the occurrence area of cerebral ischemic events is typically unpredictable, an ideal cerebral oxygen monitoring method must also possess the capability for whole-brain coverage.

To address these challenges, the world's first whole-brain multi-channel non-invasive cerebral oximetry monitor recently approved for market launch by Casibrain has successfully overcome the aforementioned technical limitations. By integrating simultaneous monitoring of key brain regions including the frontal, parietal, occipital, and temporal lobes, it achieves real-time, dynamic, objective, and quantitative monitoring of whole-brain blood oxygen parameters. This innovative design not only effectively meets the critical clinical demands for cerebral oxygen monitoring during stroke treatment, but also provides more comprehensive and reliable evidence for clinical assessment, substantially expanding both the scope and depth of cerebral oximetry evaluation.

According to stroke center statistics from China's National Health Commission, there are currently over 2,000 stroke centers nationwide, receiving more than 4 million annual visits from cerebrovascular disease patients. During the implementation of various treatments—including oral medications, intravenous thrombolysis, and neurointerventional procedures—there exists a critical clinical need for real-time, accurate, and continuous monitoring of cerebral ischemia and hypoxia. However, reliable monitoring tools have long been unavailable.

Building upon this foundation, and through comprehensive analysis incorporating medical equipment allocation levels and surgical consumable usage patterns across hospitals, the Non-invasive Whole-brain Multi-channel Cerebral Oxygen Monitor demonstrates substantial application potential. Its addressable market capacity in China is projected to reach a scale of tens of billions of RMB.

The successful approval of the Non-invasive Whole-brain Multi-channel Cerebral Oxygen Monitor represents a major breakthrough in China's stroke care sector. Originating from the critical clinical needs identified at Xuanwu Hospital, Capital Medical University, this product was developed through a national key R&D program in collaboration with leading research institutions, ultimately achieving the transition from clinical demand to market-ready solution. Its core value lies in addressing the industry-wide limitation of conventional cerebral oximetry being unable to cover the entire brain, providing unprecedented real-time, comprehensive monitoring capabilities for stroke diagnosis and treatment, and demonstrating clear market potential.

In summary, the core competitive advantages of this Non-invasive Whole-brain Multi-channel Cerebral Oxygen Monitor are primarily manifested in the following four aspects:

Serving as a real-time sentinel for cerebral ischemia, the Non-invasive Whole-brain Multi-channel Cerebral Oxygen Monitor precisely addresses the critical clinical pain point—the lack of effective monitoring methods before and after stroke treatment—successfully penetrating the vast and underserved blue ocean market of stroke monitoring. This product represents not merely an innovative technology, but a platform solution with a clear commercialization pathway, poised to redefine clinical standards across multiple high-value scenarios and unlock significant commercial potential.

The successful launch of this groundbreaking product by Casibrain not only fills a global technological gap in non-invasive, real-time oxygen monitoring across the entire brain, but also holds the potential to redefine the pathways and standards for clinical brain function monitoring. It empowers clinicians to obtain a continuous, dynamic "whole-brain oxygen map," effectively driving the transition of clinical decision-making from empirical judgment toward data-driven precision management.